TRPM3

transient receptor potential cation channel subfamily M member 3

Details

HGNC: HGNC:17992
GeneCards: TRPM3
NCBI: 80036
Ensembl: ENSG00000083067
UniProt: Q9HCF6
OMIM: 608961
UCSC: uc004aid.5
VEGA: OTTHUMG00000019997
ENA: AB046836
Alias Symbols: KIAA1616, LTRPC3, GON-2
Previous Symbols: None
Alias Names: "melastatin 2"
Previous Names: "transient receptor potential cation channel, subfamily M, member 3"

Associated Studies

Investigation into the restoration of TRPM3 ion channel activity in post-COVID-19 condition: a potential pharmacotherapeutic target

2024 | Sasso, Etianne Martini; Muraki, Katsuhiko; Eaton-Fitch, Natalie; Smith, Peter; Jeremijenko, Andrew; Griffin, Paul; Marshall-Gradisnik, Sonya

Associated cohorts
Phenotype: ME/CFS, ME/CFS - CCC criteria, ME/CFS - Fukuda criteria, ME/CFS - ICC Criteria, Post-exertional malaise (PEM)
Phenotype: Long COVID

Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients

2022 | Sasso, Etianne Martini; Muraki, Katsuhiko; Eaton-Fitch, Natalie; Smith, Peter; Lesslar, Olivia Ly; Deed, Gary; Marshall-Gradisnik, Sonya

Associated cohorts
Phenotype: ME/CFS, ME/CFS - CCC criteria, ME/CFS - Fukuda criteria, ME/CFS - ICC Criteria, Post-exertional malaise (PEM)
Phenotype: Long COVID, Long COVID - 2021 WHO criteria

Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients

2022 | Eaton-Fitch, Natalie; Du Preez, Stanley; Cabanas, Hélène; Muraki, Katsuhiko; Staines, Donald; Marshall-Gradisnik, Sonya

Associated cohorts
Phenotype: ME/CFS, Post-exertional malaise (PEM)